TRENDING :  Market Movers  |  Top 50   FDX (-2.8%)    SPY (-1.93%)    AMZN (-3%)    VXXB (11.47%)    LVS (-2.67%)    MCD (0.24%)    NFLX (-4.47%)    NRG (-2.03%)    NXST (-3.18%)    PBR (-7.22%)    PEI (0.33%)    POST (-0.17%)    PYPL (-2.77%)    QQQ (-2.2%)    ROKU (-4.53%)    SBUX (-0.42%)    SCIF (-3.28%)    SLNO (2.35%)    WYNN (-3.5%)    XLE (-2.71%)    XLF (-2.77%)    XLU (0.73%)    XRX (-5.6%)    ZUO (-14.06%)    SQ (-4.39%)

 PTI - Proteostasis Therapeutics

$4.07 [-0.23][-5.35%]

Next Earnings

3/29/2019

AMC

Recommend
Trade Idea »



OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $PTI

Service NameTrader% Success
Burdeshaw InvestingMatthew Burdeshaw55.00 %Subscribe

TRENDING ARTICLES



Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed

03/07/19
Vertex Pharmaceuticals Incorporated VRTX announced that two phase III studies evaluating its next generation CFTR corrector VX 445 in combination with tezacaftor and Kalydeco ivacaftor met the primary endpoint of significant improvement in lung function in patients suffering from